Cassini® successfully closes financing round

Cassini, a pioneer in the development of corneal diagnostic solutions, announced today that it has closed a Series A financing round with venture capital fund Innovation Industries. The injection of capital will accelerate the development and successful commercialization of Cassini, a diagnostic platform for premium refractive cataract surgery procedures.

Feb 26, 2018

N E W S  R E L E A S E

The Hague, Netherlands – Burlington MA, February 26, 2018 – Cassini, a pioneer in the development of corneal diagnostic solutions, announced today that it has closed a Series A financing round with venture capital fund Innovation Industries. The injection of capital will accelerate the development and successful commercialization of Cassini, a diagnostic platform for premium refractive cataract surgery procedures.

Since its launch in 2013, Cassini has been at the forefront of improving cataract surgery outcomes by providing diagnostic analysis of the total cornea, including the posterior surface. At the 2017 Congress of the European Society of Cataract and Refractive Surgeons in Lisbon, Portugal, twelve studies were presented demonstrating outstanding diagnostic accuracy and clinical outcomes based on Cassini’s performance. Covering a wide range of research interests, the studies focused on measurement of the posterior cornea, precision of femtosecond laser assisted arcuate incisions for correction of astigmatism and comparative studies of Cassini and other diagnostic technologies.

Jeroen Cammeraat, CEO comments, “Innovation Industries shares our long term vision of continuous innovation with the goal of delivering the best possible refractive outcomes to patients, while at the same time improving operational efficiencies and providing to surgeons and industry partners an indispensable technology platform for seamless integration of the clinic and surgical suite”.

“We are very excited about our investment in Cassini”, says Chris Sonnenberg, General Partner at Innovation Industries. “Cassini has built an impressive global customer base and has started to generate very compelling clinical data. We strongly support the vision of the leadership team to accelerate R&D and clinical study efforts to bring Cassini to the next performance level and expand strategic partnerships to other key players in the industry”.

For more information please contact:
Jeroen Cammeraat, CEO, +31 70 399 31 12
j.cammeraat@cassini-technologies.com

About Cassini®

Cassini pioneers smart and highly accurate corneal diagnostic solutions that are affordable, fast and user-friendly, providing care providers worldwide with advanced technology that best serves their patients.

Cassini helps cataract surgeons to better understand properties of the total corneal in order to improve outcomes and increase premium patient satisfaction and volume. Cassini offers a full suite of examinations required for toric, extended depth of focus and multifocal IOL implantation, including corneal topography, posterior corneal analysis, mesopic and photopic pupillometry and full color photography. The technology employs red, green yellow and infrared LEDs that are positioned in unique relationships, giving each one a GPS-like coordinate. Cassini employs the ray-tracing principle to measure relative position, using the color LEDs as triangulation points.

SEE THINGS DIFFERENT
www.cassini-technologies.com

About Innovation Industries

Innovation Industries is an independent venture capital fund which aims to support Dutch tech ventures by providing both funding as well as hands-on guidance. In order to help Dutch tech ventures succeed, we have partnered with four technical universities (Eindhoven, Twente, Delft and Wageningen) as well as research institutes (TNO, ECN and DLO). The Innovation Industries Fund is supported by private and institutional investors such as PME and InnovFin Equity. InnovFin Equity with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.

For more information about Innovation Industries see: www.innovationindustries.com

Read the full article here.

article references

Cassini, a pioneer in the development of corneal diagnostic solutions, announced today that it has closed a Series A financing round with venture capital fund Innovation Industries. The injection of capital will accelerate the development and successful commercialization of Cassini, a diagnostic platform for premium refractive cataract surgery procedures.